bibliographic resource 1851331 [br/1851331]
https://w3id.org/oc/corpus/br/1851331
- is a
-
- title
-
- Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-